firstname.lastname@example.org | 01484 472721
Dunnill, C., Al-Tameemi, W., Collett, A., Haslam, I. and Georgopoulos, N. (2017) ‘A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and its Prevention’ The Oncologist . ISSN 1083-7159
Allison, S., Sadiq, M., Baronou, E., Cooper, P., Dunnill, C., Georgopoulos, N., Latif, A., Shepherd, S., Shnyder, S., Stratford, I., Wheelhouse, R., Willans, C. and Phillips, R. (2017) ‘Preclinical anti-cancer activity and multiple mechanisms of action of a cationic silver complex bearing N-heterocyclic carbene ligands’ Cancer Letters . ISSN 0304-3835
Dunnill, C., Ibraheem, K., Mohamed, A., Southgate, J. and Georgopoulos, N. (2016) ‘A redox state-dictated signalling pathway deciphers the malignant cell specificity of CD40-mediated apoptosis’ Oncogene . ISSN 0950-9232
Baker, S., Shabir, S., Georgopoulos, N. and Southgate, J. (2016) ‘Ketamine-Induced Apoptosis in Normal Human Urothelial Cells’ The American Journal of Pathology , 186 (5), pp. 1267-1277. ISSN 0002-9440
Dunnill, C., Patton, T., Brennan, J., Barrett, J., Dryden, M., Cooke, J., Leaper, D. and Georgopoulos, N. (2015) ‘Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process’ International Wound Journal . ISSN 1742-4801
Albarbar, B., Dunnill, C. and Georgopoulos, N. (2015) ‘Regulation of cell fate by lymphotoxin (LT) receptor signalling: Functional differences and similarities of the LT system to other TNF superfamily (TNFSF) members’ Cytokine & Growth Factor Reviews , 26 (6), pp. 659-671. ISSN 1359-6101
Rubenwolf, P., Thomas, C., Denzinger, S., Hartmann, A., Burger, M., Georgopoulos, N. and Otto, W. (2015) ‘Loss of AQP3 protein expression is associated with worse progression-free and cancer-specific survival in patients with muscle-invasive bladder cancer’ World Journal of Urology . ISSN 0724-4983
Al-Tameemi, W., Dunnill, C., Hussain, O., Komen, M., van den Hurk, C., Collett, A. and Georgopoulos, N. (2014) ‘Use of in vitro human keratinocyte models to study the effect of cooling on chemotherapy drug-induced cytotoxicity’ Toxicology in Vitro , 28 (8), pp. 1366-1376. ISSN 08872333
Georgopoulos, N., Kirkwood, L. and Southgate, J. (2014) ‘A novel bidirectional positive feedback loop between Wnt/ -catenin and EGFR/ERK: role of context-specific signalling crosstalk in modulating epithelial tissue regeneration’ Journal of Cell Science , 127 (13), pp. 2967-2982. ISSN 0021-9533
Kayamba, F., Dunnill, C., Hamnett, D., Rodr�guez, A., Georgopoulos, N. and Moran, W. (2013) ‘Piperolein B, isopiperolein B and piperamide C9:1(8E): total synthesis and cytotoxicities’ RSC Advances , 3 (37), pp. 16681-16685. ISSN 2046-2069
Rubenwolf, P., Otto, W., Denzinger, S., Hofst�dter, F., Wieland, W. and Georgopoulos, N. (2013) ‘Expression of aquaporin water channels in human urothelial carcinoma: correlation of AQP3 expression with tumour grade and stage.’ World journal of urology . ISSN 1433-8726
Rubenwolf, P., Georgopoulos, N., Kirkwood, L., Baker, S. and Southgate, J. (2012) ‘Aquaporin Expression Contributes to Human Transurothelial Permeability In Vitro and Is Modulated by NaCl’ PLoS ONE , 7 (9), p. e45339. ISSN 1932-6203
Georgopoulos, N., Kirkwood, L., Varley, C., Maclaine, N., Aziz, N. and Southgate, J. (2011) ‘Immortalisation of Normal Human Urothelial Cells Compromises Differentiation Capacity.’ European urology , 60 (1), pp. 141-149. ISSN 1873-7560
Georgopoulos, N., Kirkwood, L., Walker, D. and Southgate, J. (2010) ‘Differential Regulation of Growth-Promoting Signalling Pathways by E-Cadherin’ PLoS ONE , 5 (10), p. e13621. ISSN 1932-6203
Walker, D., Georgopoulos, N. and Southgate, J. (2010) ‘Anti-social cells: Predicting the influence of E-cadherin loss on the growth of epithelial cell populations’ Journal of Theoretical Biology , 262 (3), pp. 425-440. ISSN 0022-5193
Rubenwolf, P., Georgopoulos, N., Clements, L., Feather, S., Holland, P., Thomas, D. and Southgate, J. (2009) ‘Expression and Localisation of Aquaporin Water Channels in Human Urothelium In Situ and In Vitro’ European Urology , 56 (6), pp. 1013-1024. ISSN 0302-2838
Chopra, B., Georgopoulos, N., Nicholl, A., Hinley, J., Oleksiewicz, M. and Southgate, J. (2009) ‘Structurally diverse peroxisome proliferator-activated receptor agonists induce apoptosis in human uro-epithelial cells by a receptor-independent mechanism involving store-operated calcium channels’ Cell Proliferation , 42 (5), pp. 688-700. ISSN 0960-7722
Walker, D., Georgopoulos, N. and Southgate, J. (2008) ‘From pathway to population - a multiscale model of juxtacrine EGFR-MAPK signalling’ BMC Systems Biology , 2 (1), p. 102. ISSN 1752-0509
Hill, K., Errington, F., Steele, L., Merrick, A., Morgan, R., Selby, P., Georgopoulos, N., O'Donnell, D. and Melcher, A. (2008) ‘OK432-Activated Human Dendritic Cells Kill Tumor Cells via CD40/CD40 Ligand Interactions’ Journal of Immunology , 181, pp. 3108-3115. ISSN 0022-1767
Kottke, T., Sanchez-Perez, L., Diaz, R., Thompson, J., Chong, H., Harrington, K., Calderwood, S., Pulido, J., Georgopoulos, N., Selby, P., Melcher, A. and Vile, R. (2007) ‘Induction of hsp70-Mediated Th17 Autoimmunity Can Be Exploited as Immunotherapy for Metastatic Prostate Cancer’ Cancer Research , 67 (24), pp. 11970-11979. ISSN 00085472
Georgopoulos, N., Merrick, A., Scott, N., Selby, P., Melcher, A. and Trejdosiewicz, L. (2007) ‘CD40-mediated death and cytokine secretion in colorectal cancer: A potential target for inflammatory tumour cell killing’ International Journal of Cancer , 121 (6), pp. 1373-1381. ISSN 00207136
Crallan, R., Georgopoulos, N. and Southgate, J. (2006) ‘Experimental models of human bladder carcinogenesis’ Carcinogenesis , 27 (3), pp. 374-381. ISSN 0143-3334
Steele, L., Georgopoulos, N., Southgate, J., Selby, P. and Trejdosiewicz, L. (2006) ‘Differential susceptibility to TRAIL of normal versus malignant human urothelial cells’ Cell Death and Differentiation , 13 (9), pp. 1564-1576. ISSN 1350-9047
Georgopoulos, N., Steele, L., Thomson, M., Selby, P., Southgate, J. and Trejdosiewicz, L. (2006) ‘A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation’ Cell Death and Differentiation , 13 (10), pp. 1789-1801. ISSN 1350-9047
Shaw, N., Georgopoulos, N., Southgate, J. and Trejdosiewicz, L. (2005) ‘Effects of loss of p53 and p16 function on life span and survival of human urothelial cells’ International Journal of Cancer , 116 (4), pp. 634-639. ISSN 0020-7136
Bugajska, U., Georgopoulos, N., Southgate, J., Johnson, P., Graber, P., Gordon, J., Selby, P. and Trejdosiewicz, L. (2002) ‘The Effects of Malignant Transformation on Susceptibility of Human Urothelial Cells to CD40-Mediated Apoptosis’ Journal of the National Cancer Institute , 94 (18), pp. 1381-1395. ISSN 1460-2105
Stockwin, L., Matzow, T., Georgopoulos, N., Stanbridge, L., Jones, S., Martin, I., Blair-Zajdel, M. and Blair, G. (2002) ‘Engineered expression of the Coxsackie B and adenovirus receptor (CAR) in human dendritic cells enhances recombinant adenovirus-mediated gene transfer’ Journal of Immunological Methods , 259 (1-2), pp. 205-215. ISSN 0022-1759
Georgopoulos, N., Proffitt, J. and Blair, G. (2000) ‘Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins’ Oncogene , 19 (42), pp. 4930-1935. ISSN 0950-9232
The aim of our research is to understand how the process of malignant transformation regulates epithelial cell fate. In particular, we want to determine how genetic alterations implicated in carcinogenesis influence proliferation/growth, molecular and functional cyto-differentiation as well as epithelial cell responses to pro-apoptotic signals, particularly those triggered by members of the TNF Receptor (TNFR) family of proteins. For our studies, we use epithelial cell culture models with direct physiological relevance, such as urothelial (bladder), colorectal (gut) and epidermal (skin) cells.
Prospective students who have government sponsorships/scholarships are very welcome to apply for PhD or MRes positions (please send informal enquiries by e-mail).
Positions are available in the following areas of research:
Members of the Tumour Necrosis Factor Receptor (TNFR) family regulate epithelial cell growth/proliferation as well as cell death and autophagy pathways. Our previous work has demonstrated for the first time how members of the TNFR family such as CD40, TRAIL-R, Fas and TNFR-I regulate cell growth versus apoptosis in normal, malignant and para-malignant cells with defined genetic alternations. Understanding the precise mechanisms underlying the actions of these receptors will allow the design of novel, tumour-specific anti-cancer therapies.
Using relevant epithelial cell models, we have previously shown how specific genetic alterations (over-expression of hTERT, inactivation of p53 and p16, constitutive activation of receptor tyrosine kinases, abrogation of E-cadherin function) implicated in cancer alter epithelial life-span, growth, cell adhesion and the response to death signals. Unravelling the influence of these changes in epithelial cell behaviour at the molecular level, and studying the role of signalling pathways such as those triggered by Wnt/beta-catenin and p63 family proteins, will a) help us improve our understanding of the process of carcinogenesis, b) allow better predict disease prognosis and c) may permit the design of tailored, patient-specific therapies.
We have established a collaboration with Paxman Coolers Ltd aiming to develop a deeper understanding of the effect of scalp cooling during anticancer chemotherapy. Although the Paxman cooling cap is often extremely effective at preventing chemotherapy-induced hair loss (alopecia), the success of the treatment often depends on the drug regime being administrated to the patients. Our aim is to use robust and relevant in vitro models to explore, at the cellular and molecular level, the underlying mechanisms of the differences in the responses to cooling, in order to help improve cooling cap efficiency and ultimately patient wellbeing.